Przejdź do zawartości
Merck

Przejdź do

MSST0005

SILu™Prot VEGFA Vascular endothelial growth factor A human

recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C- and 15N-labeled

Synonim(y):

SILu™Prot Vascular endothelial growth factor A

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Rozmiar/SKUDostępnośćCena netto
10 μg
Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
3350,00 zł
2847,50 zł

Informacje o tej pozycji

NACRES:
NA.12
UNSPSC Code:
23201100
Form:
lyophilized powder
Assay:
≥95% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in HEK 293 cells

2847,50 zł

Cena katalogowa3350,00 złZaoszczędź 15%
Promocja dostępna wyłącznie online

Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

​
Złóż zamówienie na produkt na zamówienie
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

human

Quality Segment

recombinant

expressed in HEK 293 cells

assay

≥95% (SDS-PAGE)

form

lyophilized powder

technique(s)

mass spectrometry (MS): suitable, protein mass spectrometry: suitable

UniProt accession no.

storage temp.

−20°C

Gene Information

human ... VEGFA(7422)

General description

SILu™ Prot VEGF165 is a recombinant, stable isotope-labeled human VEGF165 which incorporates [13C6,15N4]−Arginine and [13C6, 15N2]−Lysine. Expressed in human 293 cells, it is designed to be used as an internal standard for bioanalysis of VEGF165 by mass-spectrometry.

Suggested Quantitative Analysis Parameters
(MRM settings provided for three suggested peptides)

Biochem/physiol Actions

VEGF165 belongs to the PDGF/VEGF growth factor family characterized by the presence of eight conserved cysteine residues and a cystine knot structure1. VEGF is secreted by the majority of tumor cells and initiates angiogenesis by activating endothelial cells of existing blood vessels and promoting their migration2.
VEGF has also been implicated in correlation with poor prognosis in breast cancer2. In addition, VEGF is released in rheumatoid arthritis in response to TNF-α, increasing endothelial permeability and stimulating angiogenesis (formation of capillaries)3,4.

Physical form

Supplied as a lyophilized powder containing phosphate buffered saline

Other Notes

APMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGC

Legal Information

This product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only, including services for a third party for consideration. The buyer cannot sell or otherwise transfer this product, its components or materials made using this product or its components to a third party. Information about licenses for excluded uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice),1-302-695-1437 (fax), licensing@dupont.com.
SILu is a trademark of Sigma-Aldrich Co. LLC
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
MSST0006V6627H9166
description

recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C- and 15N-labeled

description

recombinant, expressed in HEK 293 cells, MS Protein Standard

description

IgG fraction of antiserum, lyophilized powder

description

VEGF165, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture

recombinant

expressed in HEK 293 cells

recombinant

expressed in HEK 293 cells

recombinant

-

recombinant

expressed in HEK 293 cells

assay

≥95% (SDS-PAGE)

assay

≥98% (SDS-PAGE)

assay

-

assay

>95% (SDS-PAGE)

biological source

human

biological source

human

biological source

goat

biological source

human

technique(s)

protein mass spectrometry: suitable, mass spectrometry (MS): suitable

technique(s)

mass spectrometry (MS): suitable, protein mass spectrometry: suitable

technique(s)

western blot: 1-2 μg/mL, neutralization: suitable, immunohistochemistry (formalin-fixed, paraffin-embedded sections): 5-15 μg/mL

technique(s)

cell culture | mammalian: suitable

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

UniProt accession no.

P15692

UniProt accession no.

P15692

UniProt accession no.

P15692

UniProt accession no.

P15692


Klasa składowania

11 - Combustible Solids

Co się dzieje?

WGK 1

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable



Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumenty section.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów




Questions

Reviews

No rating value

Active Filters